Patents by Inventor Duncan McVey

Duncan McVey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Simian (gorilla) adenovirus or adenoviral vectors and methods of use
    Patent number: 11359214
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: June 14, 2022
    Assignee: GenVec, Inc.
    Inventors: Douglas E. Brough, Jason G. D. Gall, Duncan McVey
  • Affenadenovirus (gorilla) or adenoviral vectors and methods of use
    Patent number: 11034975
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexone protein, and/or fiber protein.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: June 15, 2021
    Assignee: GenVec, Inc.
    Inventors: Jason G. D. Gall, Duncan McVey, Douglas E. Brough
  • SIMIAN (GORILLA) ADENOVIRUS OR ADENOVIRAL VECTORS AND METHODS OF USE
    Publication number: 20210040502
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Application
    Filed: August 25, 2020
    Publication date: February 11, 2021
    Applicant: GenVec, Inc.
    Inventors: Douglas E. Brough, Jason G.D. Gall, Duncan McVey
  • Affenadenovirus (gorilla) or adenoviral vectors and methods of use
    Patent number: 10792376
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Grant
    Filed: March 13, 2019
    Date of Patent: October 6, 2020
    Assignee: GenVec, Inc.
    Inventors: Duncan McVey, Douglas E. Brough, Jason G. D. Gall
  • Simian (gorilla) adenovirus or adenoviral vectors and methods of use
    Patent number: 10787682
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: September 29, 2020
    Assignee: GenVec, Inc.
    Inventors: Douglas E. Brough, Jason G. D. Gall, Duncan McVey
  • Malaria antigens and methods of use
    Patent number: 10780153
    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: September 22, 2020
    Assignee: GenVec, Inc.
    Inventors: Ping Chen, Duncan McVey, Douglas E. Brough, Joseph Bruder
  • Recombinant adenovirus vectored FMDV vaccines and uses thereof
    Patent number: 10493144
    Abstract: The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: December 3, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
    Inventors: Justin Widener, Leszlie Woodyard, Leonardo Siger, Douglas Brough, Damodar Ettyreddy, Jason Gall, Duncan McVey, Tom Burrage, Lauri Motes-Kreimeyer, Marc Fiorucci
  • AFFENADENOVIRUS (GORILLA) OR ADENOVIRAL VECTORS AND METHODS OF USE
    Publication number: 20190316152
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Application
    Filed: February 22, 2019
    Publication date: October 17, 2019
    Applicant: GenVec, Inc.
    Inventors: Jason G.D. Gall, Duncan McVey, Douglas E. Brough
  • AFFENADENOVIRUS (GORILLA) OR ADENOVIRAL VECTORS AND METHODS OF USE
    Publication number: 20190269794
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Application
    Filed: March 13, 2019
    Publication date: September 5, 2019
    Applicant: GenVec, Inc.
    Inventors: Duncan McVey, Douglas E. Brough, Jason G.D. Gall
  • MALARIA ANTIGENS AND METHODS OF USE
    Publication number: 20190247483
    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.
    Type: Application
    Filed: April 24, 2019
    Publication date: August 15, 2019
    Applicant: GenVec, Inc.
    Inventors: Ping Chen, Duncan McVey, Douglas E. Brough, Joseph Bruder
  • Malaria antigens and methods of use
    Patent number: 10314901
    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: June 11, 2019
    Assignee: GenVec, Inc.
    Inventors: Ping Chen, Duncan McVey, Douglas E. Brough, Joseph Bruder
  • RECOMBINANT ADENOVIRUS VECTORED FMDV VACCINES AND USES THEREOF
    Publication number: 20190134183
    Abstract: The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Application
    Filed: January 17, 2019
    Publication date: May 9, 2019
    Inventors: Justin WIDENER, Leszlie Woodyard, Leonardo Siger, Douglas Brough, Damodar Ettyreddy, Jason Gall, Duncan McVey, Tom Burrage, Lauri Motes-Kreimeyer, Marc Fiorucci
  • Affenadenovirus (gorilla) or adenoviral vectors and methods of use
    Patent number: 10272162
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: April 30, 2019
    Assignee: GenVec, Inc.
    Inventors: Duncan McVey, Douglas E. Brough, Jason G. D. Gall
  • Affenadenovirus (gorilla) or adenoviral vectors and methods of use
    Patent number: 10260074
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: April 16, 2019
    Assignee: GenVec, Inc.
    Inventors: Jason G. D. Gall, Duncan McVey, Douglas E. Brough
  • SIMIAN (GORILLA) ADENOVIRUS OR ADENOVIRAL VECTORS AND METHODS OF USE
    Publication number: 20190055579
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Application
    Filed: July 24, 2018
    Publication date: February 21, 2019
    Applicant: GenVec, Inc.
    Inventors: Douglas E. Brough, Jason G.D. Gall, Duncan McVey
  • Recombinant adenovirus vectored FMDV vaccines and uses thereof
    Patent number: 10188721
    Abstract: The present invention encompasses FMDV vaccines or compositions. The invention encompasses recombinant vectors encoding and expressing FMDV antigens, epitopes or immunogens which can be used to protect animals, in particular ovines, bovines, caprines, or swines, against FMDV.
    Type: Grant
    Filed: January 30, 2017
    Date of Patent: January 29, 2019
    Assignee: Merial, Inc.
    Inventors: Justin Widener, Leszlie Woodyard, Leonardo Siger, Douglas Brough, Damodar Ettyreddy, Jason Gall, Duncan McVey, Tom Burrage, Lauri Motes-Kreimeyer, Marc Fiorucci
  • MALARIA ANTIGENS AND METHODS OF USE
    Publication number: 20180344833
    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.
    Type: Application
    Filed: June 14, 2018
    Publication date: December 6, 2018
    Applicant: GenVec, Inc.
    Inventors: Ping Chen, Duncan McVey, Douglas E. Brough, Joseph Bruder
  • Simian (gorilla) adenovirus or adenoviral vectors and methods of use
    Patent number: 10059962
    Abstract: The invention provides an adenovirus or adenoviral vector characterized by comprising one or more particular nucleic acid sequences or one or more particular amino acid sequences, or portions thereof, pertaining to, for example, an adenoviral pIX protein, DNA polymerase protein, penton protein, hexon protein, and/or fiber protein.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: August 28, 2018
    Assignee: GenVec, Inc.
    Inventors: Douglas E. Brough, Jason G. D. Gall, Duncan McVey
  • Malaria antigens and methods of use
    Patent number: 10022432
    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: July 17, 2018
    Assignee: GenVec, Inc.
    Inventors: Ping Chen, Duncan McVey, Douglas E. Brough, Joseph Bruder
  • MALARIA ANTIGENS AND METHODS OF USE
    Publication number: 20180153979
    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.
    Type: Application
    Filed: November 1, 2017
    Publication date: June 7, 2018
    Applicant: GenVec, Inc.
    Inventors: Ping Chen, Duncan McVey, Douglas E. Brough, Joseph Bruder